Genenta Update at SITC22 Indicates Potential for Anti-Tumor Immune System Reset after Temferon™ Treatment in Glioblastoma Patients

November 7, 2022

https://www.globenewswire.com/news-release/2022/11/07/2549684/0/en/Genenta-Update-at-SITC22-Indicates-Potential-for-Anti-Tumor-Immune-System-Reset-after-Temferon-Treatment-in-Glioblastoma-Patients.html

• Signs of intra-tumor pro-inflammatory state in patients
• Temferon™ induced immune system reset in preclinical studies
• Macrophage and T cell profiles in patients’ tumor microenvironment echo preclinical findings

Read more at globenewswire.com

Related news for (GNTA)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.